S.sub.3 N chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 4, 1997
Grant Date -
N/A
app pub date -
Feb 22, 1995
filing date -
Sep 28, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel chelating compounds and the corresponding radionuclide metal chelates are useful for radiolabeling proteins such as antibodies, ligands such as biotin and anti-ligands such as streptavidin with radionuclide metals such as .sup.99m Tc, .sup.186 Re, and .sup.188 Re. The radiolabeled proteins, ligands and anti-ligands have diagnostic or therapeutic use, depending on the radionuclide metal chosen.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully